期刊
NATURE
卷 514, 期 7522, 页码 380-+出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nature13589
关键词
-
资金
- National Institutes of Health [2-PO1-CA42063, RO1-EB000244, RO1-CA115527, RO1-CA132091]
- Cancer Center Support (core) grant from the National Cancer Institute [P30-CA14051]
- NIH [R01-CA133404]
- Casimir-Lambert Fund
- NIH Centers for Cancer Nanotechnology Excellence [5-U54-CA151884-04]
- Harvard-MIT Center of Cancer Nanotechnology Excellence
- American Association for Cancer Research
- Leukemia Lymphoma Society
- [1K99CA169512]
The study of cancer genes in mouse models has traditionally relied on genetically-engineered strains made via transgenesis or gene targeting in embryonic stem cells(1). Here we describe a new method of cancer model generation using the CRISPR/Cas (clustered regularly interspaced short palindromic repeats/CRISPR-associated proteins) system in vivo in wild-type mice. We used hydrodynamic injection to deliver a CRISPR plasmid DNA expressing Cas9 and single guide RNAs (sgRNAs)(2-4) to the liver that directly target the tumour suppressor genes Pten (ref. 5) and p53 (also known as TP53 and Trp53) (ref. 6), alone and in combination. CRISPR-mediated Pten mutation led to elevated Akt phosphorylation and lipid accumulation in hepatocytes, phenocopying the effects of deletion of the gene using Cre-LoxP technology(7,8). Simultaneous targeting of Pten and p53 induced liver tumours that mimicked those caused by Cre-loxP-mediated deletion of Pten and p53. DNA sequencing of liver and tumour tissue revealed insertion or deletion mutations of the tumour suppressor genes, including bi-allelic mutations of both Pten and p53 in tumours. Furthermore, co-injection of Cas9 plasmids harbouring sgRNAs targeting the beta-catenin gene and a single-stranded DNA oligonucleotide donor carrying activating point mutations led to the generation of hepatocytes with nuclear localization of b-catenin. This study demonstrates the feasibility of direct mutation of tumour suppressor genes and oncogenes in the liver using the CRISPR/Cas system, which presents a new avenue for rapid development of liver cancer models and functional genomics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据